Skip to main content
GL Pharm Tech Corp. logo

GL Pharm Tech Corp. — Investor Relations & Filings

Ticker · 204840 ISIN · KR7204840003 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2023-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 204840

About GL Pharm Tech Corp.

http://www.glpt.co.kr/

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often referred to as a Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic voting/proxy), and financial summaries. This falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (GL Pharm Tech) disclosing a significant change (over 30%) in revenue or profit structure. This is a standard mandatory disclosure filing in the Korean market (DART system) regarding financial performance fluctuations. Since it provides specific financial data points and reasons for the change rather than just announcing the release of a report, it falls under the category of general regulatory filings. FY 2022
2023-02-01 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the administrative procedure for the meeting. Given it is a regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2022-12-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between GL PharmTech and Ocura Bioscience. It details the contract value, terms, and counterparty information. Since this is a specific regulatory filing regarding a material business contract that does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2022-12-13 Korean
유상증자결정(종속회사의주요경영사항)(주주배정증자)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory announcement regarding a capital increase (유상증자결정) for a subsidiary company (오큐라바이오사이언스). It details the number of new shares, the purpose of the funds, the issuance method (shareholder allocation), and the board resolution date. This falls under the category of capital and financing updates.
2022-12-02 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for GL PharmTech, covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial data, business operations, management discussions, and corporate governance information. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). 9M 2022
2022-11-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.